Anesthesia-Assisted vs Buprenorphine- or Clonidine-Assisted Heroin Detoxification and Naltrexone Induction: A Randomized Trial | Anesthesiology | JAMA | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.204.227.34. Please contact the publisher to request reinstatement.
1.
 National Drug Control Strategy National Data TablesWashington, DC: Office of National Drug Control Policy; March 2004
2.
 National Survey of Substance Abuse Treatment Services (N-SSATS) . Rockville, Md: Substance Abuse and Mental Health Services Administration Office of Applied Studies; 2004
3.
Amato L, Davoli M. A Perucci C, Ferri M, Faggiano F, P Mattick R. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research.  J Subst Abuse Treat. 2005;28:321-32915925266Google ScholarCrossref
4.
Gossop M, Johns A, Green L. Opiate withdrawal: inpatient vs outpatient programmes and preferred vs random assignment to treatment.  BMJ. 1986;293:103-1043089407Google ScholarCrossref
5.
Metzger DS, Woody GE, McLellan AT.  et al.  Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up.  J Acquir Immune Defic Syndr. 1993;6:1049-10568340896Google Scholar
6.
Tillim SJ. Opiate withdrawal treated with induced hypoglycemic reactions.  Am J Psychiatry. 1942;99:84-89Google Scholar
7.
Newman MK, Berris JM. Artificial hibernation therapy.  Arch Physiol Ther. 1941;22:161-167Google Scholar
8.
Kelman H. Narcotic withdrawal syndrome: suppression of by means of electric convulsive therapy.  Minn Med. 1964;47:525-52714245627Google Scholar
9.
Kolb L, Himmelsbach CK. Clinical studies of drug addiction, III: a critical review of the withdrawal treatment with method of evaluating abstinence syndromes.  Am J Psychiatry. 1938;94:759-799Google Scholar
10.
Kleber HD, Riordan CE. The treatment of narcotic withdrawal: a historical review.  J Clin Psychiatry. 1982;43:30-347045089Google Scholar
11.
Amato L, Davoli M, Ferri M, Gowing L, Perucci CA. Effectiveness of interventions on opiate withdrawal treatment: an overview of systematic reviews.  Drug Alcohol Depend. 2004;73:219-22615036544Google ScholarCrossref
12.
Stephenson J. Experts debate merits of 1-day opiate detoxification under anesthesia.  JAMA. 1997;277:363-3649010155Google ScholarCrossref
13.
Kleber H. Ultrarapid opiate detoxification.  Addiction. 1998;93:1629-16339926526Google ScholarCrossref
14.
Elman I, D'Ambra MN, Krause S.  et al.  Ultrarapid opioid detoxification: effects on cardiopulmonary physiology, stress hormones and clinical outcomes.  Drug Alcohol Depend. 2001;61:163-17211137281Google ScholarCrossref
15.
Hoffman WE, Berkowitz R, McDonald T, Hass F. Ultra-rapid opioid detoxification increases spontaneous ventilation.  J Clin Anesth. 1998;10:372-3769702615Google ScholarCrossref
16.
Hoffman WE, McDonald T, Berkowitz R. Simultaneous increases in respiration and sympathetic function during opiate detoxification.  J Neurosurg Anesthesiol. 1998;10:205-2109796603Google ScholarCrossref
17.
Kienbaum P, Thurauf N, Michel MC, Scherbaum N, Gastpar M, Peters J. Profound increase in epinephrine concentration in plasma and cardiovascular stimulation after mu-opioid receptor blockade in opioid-addicted patients during barbiturate-induced anesthesia for acute detoxification.  Anesthesiology. 1998;88:1154-11619605673Google ScholarCrossref
18.
Kienbaum P, Scherbaum N, Thurauf N, Michel MC, Gastpar M, Peters J. Acute detoxification of opioid-addicted patients with naloxone during propofol or methohexital anesthesia: a comparison of withdrawal symptoms, neuroendocrine, metabolic, and cardiovascular patterns.  Crit Care Med. 2000;28:969-97610809268Google ScholarCrossref
19.
Pfab R, Hirtl C, Zilker T. Opiate detoxification under anesthesia: no apparent benefit but suppresion of thyroid hormones and risk of pulmonary and renal failure.  J Toxicol Clin Toxicol. 1999;37:43-5010078159Google ScholarCrossref
20.
San L, Puig M, Bulbena A, Farre M. High risk of ultrashort noninvasive opiate detoxification.  Am J Psychiatry. 1995;152:9567755136Google Scholar
21.
Albanese AP, Gevirtz C, Oppenheim B, Field JM, Abels I, Eustace JC. Outcome and six-month follow up of patients after ultra rapid opiate detoxification (UROD).  J Addict Dis. 2000;19:11-2810809517Google ScholarCrossref
22.
Shreeram SS, McDonald T, Dennison S. Psychosis after ultrarapid opiate detoxification.  Am J Psychiatry. 2001;158:97011384923Google Scholar
23.
Golden SA, Sakhrani DL. Unexpected delirium during rapid opioid detoxification (ROD).  J Addict Dis. 2004;23:65-7515077841Google ScholarCrossref
24.
Bell JR, Young MR, Masterman SC, Morris A, Mattick RP, Bammer G. A pilot study of naltrexone-accelerated detoxification in opioid dependence.  Med J Aust. 1999;171:26-3010451668Google Scholar
25.
Cucchia AT, Monnat M, Spagnoli J, Ferrero F, Bertschy G. Ultra-rapid opiate detoxification using deep sedation with oral midazolam: short and long-term results.  Drug Alcohol Depend. 1998;52:243-2509839150Google ScholarCrossref
26.
Hamilton RJ, Olmedo RE, Shah S.  et al.  Complications of ultrarapid opioid detoxification with subcutaneous naltrexone pellets.  Acad Emerg Med. 2002;9:63-6811772672Google ScholarCrossref
27.
Gold CG, Cullen DJ, Gonzales S, Houtmeyers D, Dwyer MJ. Rapid opioid detoxification during general anesthesia: a review of 20 patients.  Anesthesiology. 1999;91:1639-164710598605Google ScholarCrossref
28.
Whittington RA, Collins ED, Kleber HD. Rapid opioid detoxification during general anesthesia: is death not a significant outcome?  Anesthesiology. 2000;93:1363-136411046233Google ScholarCrossref
29.
Brewer C. Rapid opiate detoxification under anaesthesia.  Hosp Med. 1999;60:7010197106Google Scholar
30.
Tretter F, Burkhardt D, Bussello-Spieth B, Reiss J, Walcher S, Buchele W. Clinical experience with antagonist-induced opiate withdrawal under anaesthesia.  Addiction. 1998;93:269-2759624727Google ScholarCrossref
31.
Ali R, Thomas P, White J.  et al.  Antagonist-precipitated heroin withdrawal under anaesthetic prior to maintenance naltrexone treatment: determinants of withdrawal severity.  Drug Alcohol Rev. 2003;22:425-43114660132Google ScholarCrossref
32.
O'Connor PG, Kosten TR. Rapid and ultrarapid opioid detoxification techniques.  JAMA. 1998;279:229-2349438745Google ScholarCrossref
33.
Carreno JE, Bobes J, Brewer C.  et al.  24-Hour opiate detoxification and antagonist induction at home—the “Asturian method”: a report on 1368 procedures.  Addict Biol. 2002;7:243-25012006220Google ScholarCrossref
34.
Brewer C, Rezae H, Bailey C. Opioid withdrawal and naltrexone induction in 48-72 hours with minimal drop-out, using a modification of the naltrexone-clonidine technique.  Br J Psychiatry. 1988;153:340-3433250670Google ScholarCrossref
35.
Hensel M, Kox WJ. Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: a prospective study in methadone, heroin, codeine and morphine addicts.  Acta Anaesthesiol Scand. 2000;44:326-33310714849Google ScholarCrossref
36.
Hensel M, Wolter S, Kox WJ. EEG controlled rapid opioid withdrawal under general anaesthesia.  Br J Anaesth. 2000;84:236-23810743458Google ScholarCrossref
37.
Rabinowitz J, Cohen H, Atias S. Outcomes of naltrexone maintenance following ultra rapid opiate detoxification vs intensive inpatient detoxification.  Am J Addict. 2002;11:52-5611876583Google ScholarCrossref
38.
Rabinowitz J, Cohen H, Kotler M. Outcomes of ultrarapid opiate detoxification combined with naltrexone maintenance and counseling.  Psychiatr Serv. 1998;49:831-8339634168Google Scholar
39.
Rabinowitz J, Cohen H, Tarrasch R, Kotler M. Compliance to naltrexone treatment after ultra-rapid opiate detoxification: an open label naturalistic study.  Drug Alcohol Depend. 1997;47:77-869298329Google ScholarCrossref
40.
Bartter T, Gooberman LL. Rapid opiate detoxification.  Am J Drug Alcohol Abuse. 1996;22:489-4958911587Google ScholarCrossref
41.
Bochud Tornay C, Favrat B, Monnat M.  et al.  Ultra-rapid opiate detoxification using deep sedation and prior oral buprenorphine preparation: long-term results.  Drug Alcohol Depend. 2003;69:283-28812633914Google ScholarCrossref
42.
Loimer N, Schmid R, Lenz K, Presslich O, Grunberger J. Acute blocking of naloxone-precipitated opiate withdrawal symptoms by methohexitone.  Br J Psychiatry. 1990;157:748-7522279212Google ScholarCrossref
43.
McGregor C, Ali R, White JM, Thomas P, Gowing L. A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months.  Drug Alcohol Depend. 2002;68:5-1412167548Google ScholarCrossref
44.
American Society of Addiction Medicine (ASAM).  Public policy statement on opioid antagonist agent detoxification under sedation or anesthesia (OADUSA).  J Addict Dis. 2000;19:109-11211110069Google Scholar
45.
Justins D. Rapid opioid detoxification under anaesthesia.  Hosp Med. 1998;59:1809722340Google Scholar
46.
Gonzalez JP, Brogden RN. Naltrexone: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence.  Drugs. 1988;35:192-2132836152Google ScholarCrossref
47.
O'Brien CP, Kampman KM. Opioids: antagonists and partial agonists. In: Galanter M, Kleber HD, eds. Textbook of Substance Abuse Treatment. 3rd ed. Washington, DC: American Psychiatric Publishing Inc; 2004
48.
Umbricht A, Montoya ID, Hoover DR, Demuth KL, Chiang CT, Preston KL. Naltrexone shortened opioid detoxification with buprenorphine.  Drug Alcohol Depend. 1999;56:181-19010529020Google ScholarCrossref
49.
O'Connor PG, Carroll KM, Shi JM, Schottenfeld RS, Kosten TR, Rounsaville BJ. Three methods of opioid detoxification in a primary care setting: a randomized trial.  Ann Intern Med. 1997;127:526-5309313020Google ScholarCrossref
50.
Comer SD, Collins ED, Fischman MW. Buprenorphine sublingual tablets: effects on IV heroin self-administration by humans.  Psychopharmacology (Berl). 2001;154:28-3711292003Google ScholarCrossref
51.
Kleber HD, Riordan CE, Rounsaville B.  et al.  Clonidine in outpatient detoxification from methadone maintenance.  Arch Gen Psychiatry. 1985;42:391-3943977557Google ScholarCrossref
52.
Carnwath T, Hardman J. Randomised double-blind comparison of lofexidine and clonidine in the out-patient treatment of opiate withdrawal.  Drug Alcohol Depend. 1998;50:251-2549649979Google ScholarCrossref
53.
McLellan AT, Kushner H, Metzger D.  et al.  The fifth edition of the Addiction Severity Index.  J Subst Abuse Treat. 1992;9:199-2131334156Google ScholarCrossref
54.
Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients.  J Pers Assess. 1996;67:588-5978991972Google ScholarCrossref
55.
Hamilton M. A rating scale for depression.  J Neurol Neurosurg Psychiatry. 1960;23:56-6214399272Google ScholarCrossref
56.
Wang RI, Wiesen RL, Lamid S, Roh BL. Rating the presence and severity of opiate dependence.  Clin Pharmacol Ther. 1974;16:653-6584422361Google Scholar
57.
Berger VW, Exner DV. Detecting selection bias in randomized clinical trials.  Control Clin Trials. 1999;20:319-32710440559Google ScholarCrossref
58.
Handelsman L, Cochrane KJ, Aronson MJ, Ness R, Rubinstein KJ, Kanof PD. Two new rating scales for opiate withdrawal.  Am J Drug Alcohol Abuse. 1987;13:293-3083687892Google ScholarCrossref
59.
Peachey JE, Lei H. Assessment of opioid dependence with naloxone.  Br J Addict. 1988;83:193-2013345396Google ScholarCrossref
60.
Liu J, Singh H, White PF. Electroencephalographic bispectral index correlates with intraoperative recall and depth of propofol-induced sedation.  Anesth Analg. 1997;84:185-1898989022Google Scholar
61.
Carroll KM, Rounsaville BJ, Keller DS. Relapse prevention strategies for the treatment of cocaine abuse.  Am J Drug Alcohol Abuse. 1991;17:249-2651928020Google ScholarCrossref
62.
Spanagel R. Is there a pharmacological basis for therapy with rapid opioid detoxification?  Lancet. 1999;354:2017-201810636363Google ScholarCrossref
63.
Presslich O, Loimer N, Lenz K, Schmid R. Opiate detoxification under general anesthesia by large doses of naloxone.  J Toxicol Clin Toxicol. 1989;27:263-2702600989Google ScholarCrossref
64.
Simon DL. Rapid opioid detoxification using opioid antagonists: history, theory and the state of the art.  J Addict Dis. 1997;16:103-1229046447Google ScholarCrossref
65.
Krabbe PF, Koning JP, Heinen N, Laheij RJ, van Cauter RM, De Jong CA. Rapid detoxification from opioid dependence under general anaesthesia vs standard methadone tapering: abstinence rates and withdrawal distress experiences.  Addict Biol. 2003;8:351-35813129838Google ScholarCrossref
66.
Kaye AD, Gevirtz C, Bosscher HA.  et al.  Ultrarapid opiate detoxification: a review.  Can J Anaesth. 2003;50:663-67112944440Google ScholarCrossref
67.
Brewer C. Ultra-rapid, antagonist-precipitated opiate detoxification under general anaesthesia or sedation.  Addict Biol. 1997;2:291-302Google ScholarCrossref
68.
Brewer C. The case for rapid detoxification under anaesthesia (RODA): a reply to Gossop and Strang.  Br J Intens Care. 1997;138-143Google Scholar
69.
Spanagel R, Kirschke C, Tretter F, Holsboer F. Forced opiate withdrawal under anaesthesia augments and prolongs the occurrence of withdrawal signs in rats.  Drug Alcohol Depend. 1998;52:251-2569839151Google ScholarCrossref
70.
Lawental E. Ultra rapid opiate detoxification as compared to 30-day inpatient detoxification program—a retrospective follow-up study.  J Subst Abuse. 2000;11:173-18110989777Google ScholarCrossref
71.
Strang J, Bearn J, Gossop M. Opiate detoxification under anaesthesia.  BMJ. 1997;315:1249-12509390045Google ScholarCrossref
72.
Rothenberg JL, Sullivan MA, Church SH.  et al.  Behavioral naltrexone therapy: an integrated treatment for opiate dependence.  J Subst Abuse Treat. 2002;23:351-36012495797Google ScholarCrossref
Original Contribution
August 24/31, 2005

Anesthesia-Assisted vs Buprenorphine- or Clonidine-Assisted Heroin Detoxification and Naltrexone Induction: A Randomized Trial

Author Affiliations
 

Author Affiliations: Division on Substance Abuse, New York State Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons of Columbia University (Drs Collins and Kleber and Ms Heitler); Department of Anesthesiology, College of Physicians and Surgeons of Columbia University (Dr Whittington).

JAMA. 2005;294(8):903-913. doi:10.1001/jama.294.8.903
Abstract

Context Rapid opioid detoxification with opioid antagonist induction using general anesthesia has emerged as an expensive, potentially dangerous, unproven approach to treat opioid dependence.

Objective To determine how anesthesia-assisted detoxification with rapid antagonist induction for heroin dependence compared with 2 alternative detoxification and antagonist induction methods.

Design, Setting, and Patients A total of 106 treatment-seeking heroin-dependent patients, aged 21 through 50 years, were randomly assigned to 1 of 3 inpatient withdrawal treatments over 72 hours followed by 12 weeks of outpatient naltrexone maintenance with relapse prevention psychotherapy. This randomized trial was conducted between 2000 and 2003 at Columbia University Medical Center’s Clinical Research Center. Outpatient treatment occurred at the Columbia University research service for substance use disorders. Patients were included if they had an American Society of Anesthesiologists physical status of I or II, were without major comorbid psychiatric illness, and were not dependent on other drugs or alcohol.

Interventions Anesthesia-assisted rapid opioid detoxification with naltrexone induction, buprenorphine-assisted rapid opioid detoxification with naltrexone induction, and clonidine-assisted opioid detoxification with delayed naltrexone induction.

Main Outcome Measures Withdrawal severity scores on objective and subjective scales; proportions of patients receiving naltrexone, completing inpatient detoxification, and retained in treatment; proportion of opioid-positive urine specimens.

Results Mean withdrawal severities were comparable across the 3 treatments. Compared with clonidine-assisted detoxification, the anesthesia- and buprenorphine-assisted detoxification interventions had significantly greater rates of naltrexone induction (94% anesthesia, 97% buprenorphine, and 21% clonidine), but the groups did not differ in rates of completion of inpatient detoxification. Treatment retention over 12 weeks was not significantly different among groups with 7 of 35 (20%) retained in the anesthesia-assisted group, 9 of 37 (24%) in the buprenorphine-assisted group, and 3 of 34 (9%) in the clonidine-assisted group. Induction with 50 mg of naltrexone significantly reduced the risk of dropping out (odds ratio, 0.28; 95% confidence interval, 0.15-0.51). There were no significant group differences in proportions of opioid-positive urine specimens. The anesthesia procedure was associated with 3 potentially life-threatening adverse events.

Conclusion These data do not support the use of general anesthesia for heroin detoxification and rapid opioid antagonist induction.

×